Aflac: Q1 Earnings Insights


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Shares of Aflac (NYSE:AFL) moved higher in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share were up 26.45% over the past year to $1.53, which beat the estimate of $1.21.

Revenue of $5,869,000,000 rose by 13.70% year over year, which beat the estimate of $5,540,000,000.

Looking Ahead

Aflac hasn't issued any earnings guidance for the time being.

Aflac hasn't issued any revenue guidance for the time being.

Technicals

52-week high: $54.05

52-week low: $30.32

Price action over last quarter: Up 17.46%

Company Overview

Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsBZI-Recaps